Skip to main content
Top

Endocrine Pathology

Issue 2/2007

Content (9 Articles)

RET Signaling in Endocrine Tumors: Delving Deeper into Molecular Mechanisms

Andrea Z. Lai, Taranjit S. Gujral, Lois M. Mulligan

The Cytoplasmic Expression of MUC1 in Papillary Thyroid Carcinoma of Different Histological Variants and its Correlation with Cyclin D1 Overexpression

Alexander Abrosimov, Vladimir Saenko, Serik Meirmanov, Masahiro Nakashima, Tatiana Rogounovitch, Olesya Shkurko, Eugeny Lushnikov, Norisato Mitsutake, Hiroyuki Namba, Shunichi Yamashita

AIP Mutations are not Identified in Patients with Sporadic Pituitary Adenomas

Rebecca DiGiovanni, Stefano Serra, Shereen Ezzat, Sylvia L. Asa

Clinical Research

Differential Expression of the Five Somatostatin Receptor Subtypes in Human Benign and Malignant Insulinomas – Predominance of Receptor Subtype 4

Guida Maria Portela-Gomes, Mats Stridsberg, Lars Grimelius, Otto Rorstad, Eva Tiensuu Janson

Pituitary Adenoma with Tumoral Granulomatous Reaction

Bernd W. Scheithauer, Ana Isabel Silva, John L. D. Atkinson, Todd B. Nippoldt, Timothy J. Kaufmann, Kalman Kovacs, Eva Horvath, Ricardo Lloyd

Case Report

A Large Sellar Granular Cell Tumor in a 21-year-old Woman

Vera Popovic, Sandra Pekic, Milica Skender-Gazibara, Fateme Salehi, Kalman Kovacs

Cushing’s Syndrome in a Child with Pancreatic Acinar Cell Carcinoma

György Illyés, Andrea Luczay, Gábor Benyó, Attila Kálmán, Katalin Borka, Katalin Köves, Károly Rácz, Tivadar Tulassay, Zsuzsa Schaff

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine